Pursuant to the regulation 30 of SEBI LODR, we wish to inform that Company has received the licenses from Food Safety and Drug Control Commissionarate, Government of Rajasthan are enclosed.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shricon Industries has received two drug wholesale distribution licenses from the Food Safety and Drug Control Commissionerate, Government of Rajasthan, both dated July 15, 2025. One license (DRUG/2025-26/136521) covers drugs specified in Schedules C and C(1), and the other (DRUG/2025-26/136520) covers drugs other than those in Schedules C, C(1), and X. The licenses are valid perpetually, subject to a retention fee every five years. The company says these licenses will enable it to expand into the pharmaceutical, nutraceuticals, and ayurveda sectors, and will positively contribute to growth prospects.
This is a regulatory clearance that opens a new business vertical (pharma/nutraceutical/ayurveda wholesale distribution) for Shricon Industries. It is a positive strategic development, though actual revenue impact will depend on how quickly the company scales operations in this new segment.